Mark Daniel B, Pan Wenqin, Clapp-Channing Nancy E, Anstrom Kevin J, Ross John R, Fox Rebecca S, Devlin Gerard P, Martin C Edwin, Adlbrecht Christopher, Cowper Patricia A, Ray Linda Davidson, Cohen Eric A, Lamas Gervasio A, Hochman Judith S
Outcomes Research Group, Duke Clinical Research Institute, and the Department of Medicine, Duke University Medical Center, Durham, NC, USA.
N Engl J Med. 2009 Feb 19;360(8):774-83. doi: 10.1056/NEJMoa0805151.
The open-artery hypothesis postulates that late opening of an infarct-related artery after myocardial infarction will improve clinical outcomes. We evaluated the quality-of-life and economic outcomes associated with the use of this strategy.
We compared percutaneous coronary intervention (PCI) plus stenting with medical therapy alone in high-risk patients in stable condition who had a totally occluded infarct-related artery 3 to 28 days after myocardial infarction. In 951 patients (44% of those eligible), we assessed quality of life by means of a battery of tests that included two principal outcome measures, the Duke Activity Status Index (DASI) (which measures cardiac physical function on a scale from 0 to 58, with higher scores indicating better function) and the Medical Outcomes Study 36-Item Short-Form Mental Health Inventory 5 (which measures psychological well-being). Structured quality-of-life interviews were performed at baseline and at 4, 12, and 24 months. Costs of treatment were assessed for 458 of 469 patients in the United States (98%), and 2-year cost-effectiveness was estimated.
At 4 months, the medical-therapy group, as compared with the PCI group, had a clinically marginal decrease of 3.4 points in the DASI score (P=0.007). At 1 and 2 years, the differences were smaller. No significant differences in psychological well-being were observed. For the 469 patients in the United States, cumulative 2-year costs were approximately $7,000 higher in the PCI group (P<0.001), and the quality-adjusted survival was marginally longer in the medical-therapy group.
PCI was associated with a marginal advantage in cardiac physical function at 4 months but not thereafter. At 2 years, medical therapy remained significantly less expensive than routine PCI and was associated with marginally longer quality-adjusted survival. (ClinicalTrials.gov number, NCT00004562.)
开放动脉假说认为,心肌梗死后梗死相关动脉的延迟开通将改善临床结局。我们评估了采用该策略相关的生活质量和经济结局。
我们将经皮冠状动脉介入治疗(PCI)加支架置入术与单纯药物治疗进行了比较,研究对象为心肌梗死后3至28天梗死相关动脉完全闭塞的病情稳定的高危患者。在951例患者(占符合条件者的44%)中,我们通过一系列测试评估生活质量,这些测试包括两项主要结局指标,即杜克活动状态指数(DASI)(该指数衡量心脏身体功能,范围为0至58分,分数越高表明功能越好)和医学结局研究36项简版心理健康量表5(该量表衡量心理健康状况)。在基线以及4个月、12个月和24个月时进行结构化的生活质量访谈。对美国469例患者中的458例(98%)评估了治疗费用,并估算了2年的成本效益。
在4个月时,与PCI组相比,药物治疗组的DASI评分在临床上略有下降,下降了3.4分(P = 0.007)。在1年和2年时,差异较小。未观察到心理健康方面的显著差异。对于美国的469例患者,PCI组的2年累计费用比药物治疗组高出约7000美元(P < 0.001),且药物治疗组的质量调整生存期略长。
PCI在4个月时在心脏身体功能方面具有微弱优势,但此后则不然。在2年时,药物治疗仍然比常规PCI便宜得多,并且与略长的质量调整生存期相关。(ClinicalTrials.gov编号,NCT00004562。)